Development, Solubility Enhancement and Characterization of Nimodipine Solid Dispersions
DOI:
https://doi.org/10.37285/ijpsn.2018.11.5.2Abstract
The main aim of this study was to formulate and characterize nimodipine solid dispersions using various novel polymers. Solid dispersions were prepared by solvent evaporation method in order to improve the solubility and overall bioavailability of nimodipine. Solubility and dissolution studies indicate that Kolliwax RH 40 is the most suitable polymer. The solubility studies was corresponded with dissolution data and the formulation SD15 was found to be having highest drug release of about 98.96 ± 5.15% in about 90 minutes. In vitro release data from several formulations containing Nimodipine was determined kinetically using different mathematical models like Zero order, First order, Higuchi, and Korsmeyer–Peppas model. XRD and SEM studies indicate no crystallinity in the optimized formulation SD15. FTIR studies suggested good drug excipient compatibility between all components of prepared formulation. These results confirm the viability of enhancing the solubility of nimodipine by formulating the drug as solid dispersions in Kolliwax.
Downloads
Metrics
Keywords:
Nimodipine, Solid dispersions, Solvent evaporation, Solubility, Kolliwax
Downloads
Published
How to Cite
Issue
Section
References
Bolla N, Chandra S, Rao GSNK, and Devi PU (2013). Improvement of simvastatin solubility using natural polymers by solid dispersion technique. International journal of pharmaceutical research and biomedical analysis 2(2): 01-06.
Chaulang G, Patel P, Hardikar S, Kelkar M, Bhosale A, and Bhise S (2009). Formulation and Evaluation of Solid Dispersions of Furosemide in Sodium Starch Glycolate. Tropical Journal of Pharmaceutical Research 8(1): 43-51.
Chen S, Zhu J, Ma F, Fang Q, and Li Y (2007). Preparation and characterization of solid dispersions of dipyridamole with a carrier "copolyvidonum Plasdone S-630". Drug Dev Ind Pharm 33(8): 888-99.
Costa P and Sousa LJM (2001). Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Science 13(2):123-133.
Dehghan MH and Jafar M (2006). Improving Dissolution of Meloxicam using solid dispersions. Iranian J Pharm Research 4: 231‐238.
Dhirendra K, Lewis S, and Udupa N (2009). Solid Dispersions: A Review. Pak. J. Pharm. Sci. 22(2):234-246.
Emara LH, Badr RM and Abd EA (2002). Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers. Drug Dev Ind Pharm 28: 795‐807.
Hörter D and Dressman JB (2001). Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 46: 75-87.
Jatwani S, Rana AC, Singh G, and Aggarwal G (2011). Solubility and Dissolution enhancement of simvastatin using synergistic effect of hydrophilic carriers. Der Pharmacia Lettre 3(6): 280-293.
Lakshmi K, Reddy MPK, and Kaza R (2012). Dissolution enhancement of telmisartan by surface solid dispersion technology. International Journal of Innovative Pharmaceutical Research 3(4): 247-251.
Leuner C and Dressman J (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50: 47-60.
Manjit J and Rupesh D (2015). Nanoemulsion an advanced mode of drug delivery system. Biotech Journal 5(2): 123–127.
Patel A, Prajapati P, Boghra R, and Shah D (2011). Solubility enhancement of poorly aqueous soluble Furosemide using peg-4000 by solid dispersion. Asian Journal of Pharmaceutical Sciences and Clinical Research 2(1): 1-9.
Patel DM, Shah RR, and Jogani PD (2004). Tablet formulation of piroxicam containing PVP K‐30 and sodium lauryl sulphate. Indian J Pharm Sci 66: 49‐55.
Shamma RN and Basha M (2013). Soluplus®: A novel polymeric solubilizers for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation. Powder Technology 237: 406-414.
